Close



Jun 16, 2023 07:05AM
May 4, 2023 07:00AM
Mar 9, 2023 07:00AM
Nov 7, 2022 08:00AM
Nov 2, 2022 06:31AM
Nov 2, 2022 06:30AM
Oct 19, 2022 07:03AM Surface (SURF) and VIB Report Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388
Oct 19, 2022 07:00AM
Sep 14, 2022 07:30AM
Aug 3, 2022 07:00AM
Jun 20, 2022 10:05AM
May 26, 2022 05:06PM
May 26, 2022 05:00PM
May 9, 2022 07:10AM Surface Oncology (SURF) Reports Q1 EPS of $0.13, Provides Corporate Highlights
May 9, 2022 07:10AM
Apr 27, 2022 04:15PM
Apr 14, 2022 07:30AM
Apr 8, 2022 04:02PM
Apr 8, 2022 04:01PM
Mar 2, 2022 07:11AM
Mar 2, 2022 07:10AM Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021
Dec 6, 2021 09:31AM
Dec 6, 2021 09:30AM
Dec 1, 2021 07:03AM
Dec 1, 2021 07:00AM
Nov 2, 2021 07:00AM
Oct 4, 2021 07:00AM
Jun 4, 2021 07:05AM Surface Oncology (SURF) Announces SRF388 Demonstrates Monotherapy Activity in Data Presented at American Society of Clinical Oncology Annual Meeting
Jun 4, 2021 07:05AM
Jun 4, 2021 07:02AM
Jun 4, 2021 07:00AM
May 5, 2021 06:45AM
Apr 28, 2021 04:05PM
Apr 9, 2021 07:54AM
Apr 9, 2021 07:53AM Surface Oncology Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at the American Association for Cancer Research Annual Meeting
Mar 31, 2021 09:22AM
Mar 30, 2021 05:42PM
Mar 30, 2021 04:30PM
Mar 30, 2021 04:30PM
Mar 29, 2021 03:57PM
Mar 9, 2021 09:26AM
Mar 9, 2021 07:02AM Surface Oncology (SURF) to Collaborate with Merck (MRK) on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, in Combination with KEYTRUDA in Patients with Solid Tumors
Mar 9, 2021 07:00AM
Nov 13, 2020 07:10AM
Nov 13, 2020 07:05AM
Nov 11, 2020 09:29AM
Nov 11, 2020 07:04AM
Nov 11, 2020 07:00AM
May 12, 2020 06:20AM Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020
Jan 28, 2020 09:23AM

251,615 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All